Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Capital in Excess of Par
Capital in Excess of Par
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Beginning balance (in shares) at Dec. 31, 2021       61,371,000 61,371,000          
Beginning balance at Dec. 31, 2021 $ 1,865,768 $ 530,732 $ 2,396,500 $ 614 $ 614 $ 4,012,358 $ 4,012,358 $ (2,147,204) $ 530,732 $ (1,616,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (7,715)             (7,715)    
Restricted stock units (in shares)       6,000            
Restricted stock units 2,790         2,790        
Common stock issued for Primexx Acquisition (in shares)       117,000            
Common stock issued for Primexx Acquisition 6,295     $ 1   6,294        
Ending balance (in shares) at Mar. 31, 2022 [1]       61,494,000            
Ending balance at Mar. 31, 2022 [1] 2,397,870     $ 615   4,021,442   (1,624,187)    
Beginning balance (in shares) at Dec. 31, 2021       61,371,000 61,371,000          
Beginning balance at Dec. 31, 2021 1,865,768 $ 530,732 $ 2,396,500 $ 614 $ 614 4,012,358 $ 4,012,358 (2,147,204) $ 530,732 $ (1,616,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) [2],[3] 797,575                  
Ending balance (in shares) at Sep. 30, 2022 [1]       61,607,000            
Ending balance at Sep. 30, 2022 [1] 3,199,960     $ 616   4,018,241   (818,897)    
Beginning balance (in shares) at Mar. 31, 2022 [1]       61,494,000            
Beginning balance at Mar. 31, 2022 [1] 2,397,870     $ 615   4,021,442   (1,624,187)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 303,251             303,251    
Restricted stock units (in shares)       244,000            
Restricted stock units (1,899)     $ 2   (1,901)        
Common stock issued for Percussion Acquisition (in shares)       (22,000)            
Common stock issued for Primexx Acquisition (1,363)         (1,363)        
Ending balance (in shares) at Jun. 30, 2022 [1]       61,716,000            
Ending balance at Jun. 30, 2022 [1] 2,697,859     $ 617   4,018,178   (1,320,936)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 502,039 [3]             502,039    
Restricted stock units (in shares)       1,000            
Restricted stock units 3,893         3,893        
Common stock issued for Percussion Acquisition (in shares)       (110,000)            
Common stock issued for Primexx Acquisition (3,831)     $ (1)   (3,830)        
Ending balance (in shares) at Sep. 30, 2022 [1]       61,607,000            
Ending balance at Sep. 30, 2022 [1] $ 3,199,960     $ 616   4,018,241   (818,897)    
Beginning balance (in shares) at Dec. 31, 2022 61,621,518     61,622,000 [1]            
Beginning balance at Dec. 31, 2022 [1] $ 3,425,781 [4]     $ 616   4,022,194   (597,029)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 220,638             220,638    
Restricted stock units (in shares)       3,000            
Restricted stock units 3,339         3,339        
Ending balance (in shares) at Mar. 31, 2023       61,625,000            
Ending balance at Mar. 31, 2023 $ 3,649,758     $ 616   4,025,533   (376,391)    
Beginning balance (in shares) at Dec. 31, 2022 61,621,518     61,622,000 [1]            
Beginning balance at Dec. 31, 2022 [1] $ 3,425,781 [4]     $ 616   4,022,194   (597,029)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) $ 232,226                  
Ending balance (in shares) at Sep. 30, 2023 67,770,721     67,771,000            
Ending balance at Sep. 30, 2023 $ 3,861,058     $ 678   4,225,183   (364,803)    
Beginning balance (in shares) at Mar. 31, 2023       61,625,000            
Beginning balance at Mar. 31, 2023 3,649,758     $ 616   4,025,533   (376,391)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (107,896)             (107,896)    
Restricted stock units (in shares)       263,000            
Restricted stock units 810     $ 3   807        
Ending balance (in shares) at Jun. 30, 2023       61,888,000            
Ending balance at Jun. 30, 2023 3,542,672     $ 619   4,026,340   (484,287)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 119,484             119,484    
Restricted stock units (in shares)       2,000            
Restricted stock units 3,881         3,881        
Common stock issued for Primexx Acquisition (in shares)       6,267,000            
Common stock issued for Primexx Acquisition 210,000     $ 63   209,937        
Repurchase and retirement of common stock $ (14,979)     $ (4)   (14,975)        
Repurchase and retirement of common stock (in shares)       (386,000)            
Ending balance (in shares) at Sep. 30, 2023 67,770,721     67,771,000            
Ending balance at Sep. 30, 2023 $ 3,861,058     $ 678   $ 4,225,183   $ (364,803)    
[1] Financial information for prior periods has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.
[2] Financial information for the prior period has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information
[3] Financial information for the prior period has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.
[4] Financial information for the prior period has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.